Abstract
Chronic kidney disease (CKD) prevalence is constantly increasing, and dyslipidemia in this disease is characteristic, favoring cardiovascular events. However, the mechanisms of CKD dyslipidemia are not fully understood. The use of curcumin (CUR) in CKD models such as 5/6 nephrectomy (5/6Nx) has shown multiple beneficial effects, so it has been proposed to correct dyslipidemia without side effects. This work aimed to characterize CUR’s potential therapeutic effect on dyslipidemia and alterations in lipid metabolism and mitochondrial ß-oxidation in the liver and kidney in 5/6Nx. Male Wistar rats were subjected to 5/6Nx and progressed by 4 weeks; meanwhile, CUR (120 mg/kg) was administered for weeks 5 to 8. Our results showed that CUR reversed the increase in liver and kidney damage and hypertriglyceridemia induced by 5/6Nx. CUR also reversed mitochondrial membrane depolarization and β-oxidation disorders in the kidney and the increased lipid uptake and the high levels of proteins involved in fatty acid synthesis in the liver and kidney. CUR also decreased lipogenesis and increased mitochondrial biogenesis markers in the liver. Therefore, we concluded that the therapeutic effect of curcumin on 5/6Nx hypertriglyceridemia is associated with the restoration of renal mitochondrial ß-oxidation and the reduction in lipid synthesis and uptake in the kidneys and liver.
Funder
Consejo Nacional de Ciencia y Tecnología
National Autonomous University of Mexico
Fondos de Gasto Directo Autorizado autorizado a la Subdirección de Investigación Básica at the Insittuo Nacional de Cardiología Ignacio Chávez
Subject
Cell Biology,Clinical Biochemistry,Molecular Biology,Biochemistry,Physiology
Reference68 articles.
1. Prevalence and Disease Burden of Chronic Kidney Disease;Adv. Exp Med. Biol.,2019
2. Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease;Kidney Int.,2020
3. Diabetes Canada Clinical Practice Guidelines Expert Committee, Mancini, G.B.J., Hegele, R.A., and Leiter, L.A. (2018). Dyslipidemia. Can. J. Diabetes, 42, S178–S185.
4. Lipoprotein Metabolism;Am. J. Kidney Dis.,1993
5. What Is Lipotoxicity?;Adv. Exp. Med. Biol.,2017
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献